Institute of Neurodegenerative Diseases CNRS-Université Victor Ségalen-Bordeaux 2 Thomas Boraud MD, PhD Neural substrates.

Slides:



Advertisements
Similar presentations
Control of dopamine ascending pathways by central 5-HT system:
Advertisements

1 Chapter 49 Neurotransmitters and Disorders of the Basal Ganglia Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All.
The Drug Discovery Process
Parkinson’s disease (PD) is one of the most common chronic progressive neurodegenerative diseases. PD has a prevalence of 1.2 million people in Europe.
Cyclic Voltametry for the Detection of Dopamine in vivo
Edward L. Bartlett Ph.D., University of Wisconsin –Auditory thalamus in vitro synaptic physiology and anatomy Postdoctoral Research at Johns Hopkins University.
Electrophysiology of neurons. Some things to remember…
Parkinson’s Cognitive Problems versus Other Neurological Diseases 14 February 2015 Carole A. Mazurowski, PhD Health Psychology & Neuropsychology 6565 Americas.
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
Introduction to the mathematical modeling of neuronal networks Amitabha Bose Jawaharlal Nehru University & New Jersey Institute of Technology IISER, Pune.
Neural Mechanisms of Memory Storage Molecular, synaptic, and cellular events store information in the nervous system. New learning and memory formation.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Basal Ganglia. Involved in the control of movement Dysfunction associated with Parkinson’s and Huntington’s disease Site of surgical procedures -- Deep.
A framework for psychopathology
Aaron Mulheren, Kathryn Wilson, MSN, APN, Milind Deogaonkar, MD
GDRE EARLY PROGRAMMING OF MODERN DISEASES Stefania MACCARI, FR
Making Things Happen - 2 Motor Disorders How Your Brain Works - Week 7 Dr. Jan Schnupp HowYourBrainWorks.net.
The Basal Ganglia. I.Functional anatomy A. Input and output components cerebral cortex  BG  thalamus (VA)  frontal lobe. B. Parallel circuits C. Neurotransmitters.
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT Supervisor : Dr Towhidkhah Designed by Yashar Sarbaz Amirkabir University of Technology.
Matt Mehne, USC Brain Project 1 USC Brain Project Matt Mehne – Progress Update – May 15, 2007 Modeling Action Selection in the Parkinsonian Basal Ganglia.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Burst Synchronization transition in neuronal network of networks Sun Xiaojuan Tsinghua University ICCN2010, Suzhou
The Cancer Systems Biology Consortium (CSBC)
Basic Behavioral Neurobiology of Drug Addiction J. David Jentsch, Ph.D. Assistant Professor of Psychology (Behavioral Neuroscience)
Chapter 16. Basal Ganglia Models for Autonomous Behavior Learning in Creating Brain-Like Intelligence, Sendhoff et al. Course: Robots Learning from Humans.
Neuroscience and Behavior. 2 Neurons Neurons are similar to other cells in the body because: Neurons are surrounded by a cell membrane. Neurons have a.
NOD Capitalizing on what drives biomedical science and scientists? –Curiosity –Competition (fame and fortune?) –Desire to solve a health problem.
Investigate biophysical, molecular and cellular mechanisms of synaptic transmission and plasticity under normal and pathological conditions-link between.
Neuroscience Resources in PsycINFO Topics in PsycINFO of Relevance to Neuroscience PsycINFO is a research database published by the American Psychological.
Genes, Cognition and Emotion Daniel R. Weinberger, M.D. Genes, Cognition and Psychosis Program National Institute of Mental Health, NIH Bethesda, Maryland.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Cognitive Psychology PSYC231 Cognition and the Brain: Basic Principles 2 Dr. Jan Lauwereyns, EA619, ext
Non-motor symptoms of PD revealed in mice with reduced vesicular storage Tonya Taylor MSP Symposium May 29, 2009.
Not a response to reward itself, but to information about reward More than predicted in ‘previous state’ = increased activity; positive prediction.
Eight genes that make us brainiacs Genes and Human 郭承玉
A RECURRENT NETWORK IN THE LATERAL AMYGDALA: A MECHANISM FOR TEMPORAL COINCIDENCE DETECTION V. DOYERE 1, L. R. JOHNSON 2, M. HOU 2, A. PONCE 3, L. GRIBELYUK.
Under the supervision of miklós jászberényi
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
The Neural Basis of Addiction : A Pathology of Motivation and Choice Am J Psychiatry 162 : , August 2005.
The NIMH Research Domain Criteria Initiative (RDoC): A Framework for Psychopathology Research February 20, 2014 Jill Heemskerk, PhD Deputy Director, Division.
Neurochemistry of executive functions
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
The Placebo Response and Effect  Can be significant  30% or more in certain interventions  An individual’s overall disease manifestation and treatment.
NETWORK INTERACTIONS IN SZ – THERAPEUTIC IMPLICATIONS
Neurophysiology Neuropsychiatric & Neurodegenerative disorders
OMICS Journals are welcoming Submissions
Paper Two Revision: OCD
Project promoter: Tallinn University of Technology
Comparing Single and Multiple Neuron Simulations of Integrated Dorsal and Ventral Striatal Pathway Models of Action Initiation Selin Metin1, Neslihan Serap.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Andres M. Lozano, Nir Lipsman  Neuron 
Figure 4 Time course of the development of physiological changes
Basal ganglia movement modulation
Narcotic drugs introduction
A C B.
Basal ganglia function
Volume 65, Pages 1-13 (December 2016)
Psychiatric Disorders: Diagnosis to Therapy
Lithium: Mechanism of Action
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT
Stimulation on Demand: Closing the Loop on Deep Brain Stimulation
Figure 3 Potential interplay between physiological
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups.
Psychiatric Disorders: Diagnosis to Therapy
Neurodegenerative diseases
Presentation transcript:

Institute of Neurodegenerative Diseases CNRS-Université Victor Ségalen-Bordeaux 2 Thomas Boraud MD, PhD Neural substrates of motivated behaviours

Research Topics Cellular Degeneration Parkinsonian Syndroms Synaptic Plasticity and Pathology Interaction between receptors and neurotransmitters Neural networks on simplified preparations Dynamic properties of cortex-basal ganglia loops Functional Reorganization in pathological conditions Control mechanisms Protein Agregats - regulation Genetic and environmental models Pathophysiology from the network to the cellular signaling LID & ICD – Relationship with addiction and modelisation Development and preclinical validation of new therapeutic approaches Ecological, Genetic, Pharmacological and/or Surgical approaches Clinical Studies Cognition - Dementia Physiology et pathophysiology of cortex-basal ganglia loops Animal Models, Electrophysiology, Imaging Clinical Research

Vertical and Translational Approach Neurotransmitter Receptors Subtypes Interactions Channel Subcellular Signaling Cascade Morphology Neuronal Phenotype Electrophysiology Transcriptional Activity Network Level Behaviour Cellular Level Metabolic Marker Imaging Plasticity Electrophysiology Target Acquisition & locking Behavioural Studies

Longitudinal Approach Time % of neurones Presymptomatic Symptoms Honeymoon Stable phase Diagnosis Decompensation Aging Neurodegenerative Disorders Early (perinatal?)

10 Research Teams Approche systémique de la boucle extrapyramidale T. Boraud Monoamines, Stimulation cérébrale profonde et maladie de Parkinson A. Benazzouz Oscillations Neuronales dans le réseau des Ganglions de la Base B. Bioulac (transition) Addiction, compulsion et syndrome de dysrégulation dopaminergique S. Ahmed Physiologie et physiopathologie des relations thalamo-frontales P. Burbaud Physiopathologie des syndromes parkinsoniens E. Bezard Neurogénétique et vieillissement dans les maladies neurodégénératives C. Lo Bianco Approches innovantes pour la prise en charge des maladies neurodégénératives C. Gross Régulation Moléculaire des Récepteurs Synaptiques E. Boué-Grabot Dynamique des réseaux neuronaux et vasculaires dans les processus mnésiques B. Bontempi

Methods Multiple Electrode Recordings Juxta-Intra and Extracellular Recordings Behavioral Studies in Rodents and Primates Electrochemical detection Theoretical approach Neural substrates of motivated behaviours Research Topics Dynamic Properties of the CBG Loop Dopamine and associated pathologies Physiology of Decision Making CUE GO 025%33%40%60%67%75%100% PETHs P values PETHs Raster Peth Cue Go Analysis method 200 ms Normalisation [Response – basal] Relevant neural information

Example: Role of the CBG loop in decision maling process A B P( ) =1 P( ) =2/3 C D P( ) =1/3 P( ) =0 P( ) A A A A A B B B B B Cortex Striatum GPi STN Thalamus n=235 * Learning Model Pathophysiogy, etc…